| |
Experience, Expertise, a Strong Network, and Close Working
Relationships
The General
Partners of EuclidSR Partners comprise an extraordinary range of venture, corporate and entrepreneurial-development backgrounds.
We have particularly strong expertise in discovery research and drug development
in the pharmaceutical industry, which is essential to the partnership's investment focus.
ESR is a $250 million venture partnership organized by our team and the fifth
since the founding of our original predecessor partnership, Euclid Partners,
more than three decades ago. Our experience also encompasses two decades of
corporate pharmaceutical venture investing through S.R. One, Limited.
Our partnership offers both investors and entrepreneurs the potential for
significant returns, through its combination of the General Partners' resources,
highly varied industry experience, hands-on operational expertise and widely
different networks of contacts.
|
